J. Verhelst

1.7k total citations
41 papers, 1.3k citations indexed

About

J. Verhelst is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, J. Verhelst has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in J. Verhelst's work include Pituitary Gland Disorders and Treatments (17 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Adrenal and Paraganglionic Tumors (6 papers). J. Verhelst is often cited by papers focused on Pituitary Gland Disorders and Treatments (17 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Adrenal and Paraganglionic Tumors (6 papers). J. Verhelst collaborates with scholars based in Belgium, United Kingdom and Curacao. J. Verhelst's co-authors include C. Mahler, Ashley Grossman, L. Denis, Peter Trainer, Trevor A. Howlett, Roger Abs, John Wass, Joris Berwaerts, Lesley Rees and G. M. Besser and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Journal of Allergy and Clinical Immunology.

In The Last Decade

J. Verhelst

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Verhelst Belgium 16 969 448 221 179 110 41 1.3k
Charles Mahler Belgium 13 786 0.8× 374 0.8× 169 0.8× 111 0.6× 65 0.6× 21 1.1k
William F. Young United States 11 767 0.8× 322 0.7× 219 1.0× 73 0.4× 65 0.6× 19 1.1k
M Grußendorf Germany 17 909 0.9× 333 0.7× 205 0.9× 37 0.2× 102 0.9× 42 1.1k
Bendt Brock Jacobsen Denmark 23 532 0.5× 348 0.8× 57 0.3× 154 0.9× 71 0.6× 60 1.3k
Fady Hannah‐Shmouni United States 18 499 0.5× 287 0.6× 187 0.8× 62 0.3× 132 1.2× 85 1.2k
Katarzyna Ziemnicka Poland 20 451 0.5× 159 0.4× 234 1.1× 51 0.3× 168 1.5× 89 972
Anouk N.A. van der Horst‐Schrivers Netherlands 20 794 0.8× 594 1.3× 314 1.4× 59 0.3× 267 2.4× 58 1.3k
Carles Zafón Spain 18 518 0.5× 179 0.4× 105 0.5× 86 0.5× 142 1.3× 73 968
A. Murat France 16 659 0.7× 423 0.9× 460 2.1× 30 0.2× 288 2.6× 45 1.1k
Dario Tumino Italy 19 1.6k 1.6× 859 1.9× 233 1.1× 41 0.2× 144 1.3× 41 1.8k

Countries citing papers authored by J. Verhelst

Since Specialization
Citations

This map shows the geographic impact of J. Verhelst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Verhelst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Verhelst more than expected).

Fields of papers citing papers by J. Verhelst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Verhelst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Verhelst. The network helps show where J. Verhelst may publish in the future.

Co-authorship network of co-authors of J. Verhelst

This figure shows the co-authorship network connecting the top 25 collaborators of J. Verhelst. A scholar is included among the top collaborators of J. Verhelst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Verhelst. J. Verhelst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burgers, P.T.P.W., et al.. (2014). Implementing a clinical pathway for hip fractures; Effects on hospital length of stay and complication rates in five hundred and twenty six patients. EUR Research Repository (Erasmus University Rotterdam). 2 indexed citations
2.
Abrams, Paul, et al.. (2010). PANHYPOPITUITARISM APPARENTLY CAUSED BY HYPOPHYSITIS MASKING A RAPID DEVELOPMENT OF A CRANIOPHARYNGIOMA. A CASE REPORT.. Acta Clinica Belgica. 65(2). 133–135. 1 indexed citations
3.
Abrams, Pascale, J. Verhelst, Kris Poppe, et al.. (2004). Efficacy and tolerability of lanreotide Autogel therapy in acromegalic patients previously treated with octreotide LAR. European Journal of Endocrinology. 151(3). 317–324. 76 indexed citations
4.
Verhelst, J., Roger Abs, M Montini, et al.. (2000). Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients. European Journal of Endocrinology. 143(5). 577–584. 53 indexed citations
5.
Verhelst, J., et al.. (1999). Ectopic macroprolactinoma mimicking a chordoma: a case report.. Endocrine Related Cancer. 6(1). 117–122. 19 indexed citations
6.
Berwaerts, Joris, J. Verhelst, C. Mahler, & Roger Abs. (1999). Cushing's syndrome in pregnancy treated by ketoconazole: Case report and review of the literature. Gynecological Endocrinology. 13(3). 175–182. 68 indexed citations
7.
Verhelst, J., et al.. (1998). Obstructive Hydrocephalus as Complication of a Giant Nonfunctioning Pituitary Adenoma: Therapeutical Approach. Acta Clinica Belgica. 53(1). 47–52. 10 indexed citations
8.
Verhelst, J., et al.. (1998). Clinical Pharmacokinetics of the Antiandrogens and Their Efficacy in Prostate Cancer. Clinical Pharmacokinetics. 34(5). 405–417. 63 indexed citations
9.
Verhelst, J., Roger Abs, Jean Mockel, et al.. (1996). Two years or replacement therapy in 148 adults with growth hormone déficiency in Belgium. Open Repository and Bibliography (University of Liège). 1 indexed citations
10.
Sener, Abdullah, et al.. (1995). Factitious Hypoglycaemia Documented by a Modified Assay for the Measurement of Plasma Sulphonylurea. Diabetic Medicine. 12(5). 433–435. 8 indexed citations
11.
Verhelst, J., et al.. (1995). Pituitary Metastasis Mimicking A Pituitary Adenoma. Acta Clinica Belgica. 50(1). 31–35. 6 indexed citations
12.
Verhelst, J., L. Denis, Peter Van de Vliet, et al.. (1994). Endocrine profiles during administration of the new non‐steroidal anti‐androgen Casodex in prostate cancer. Clinical Endocrinology. 41(4). 525–530. 89 indexed citations
13.
Mahler, C., J. Verhelst, & L. Denis. (1993). Ketoconazole and liarozole in the treatment of advanced prostatic cancer. Cancer. 71(S3). 1068–1073. 67 indexed citations
14.
Verhelst, J., et al.. (1993). Clinical and endocrine effects of laser vaporization in patients with polycystic ovarian disease. Gynecological Endocrinology. 7(1). 49–55. 11 indexed citations
15.
Trainer, Peter, J. Verhelst, Trevor A. Howlett, et al.. (1993). Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successfuI treatment. Clinical Endocrinology. 38(1). 73–78. 224 indexed citations
16.
Beckers, Albert, et al.. (1992). Le traitement des prolactinomes par un nouvel agoniste dopaminergique (le CV 205-502) : résultats chez 48 patients.. Open Repository and Bibliography (University of Liège). 1 indexed citations
17.
Verhelst, J., G. Smets, Günter Klöppel, et al.. (1992). Failure of total hypophysectomy to remove intrasellar microadenoma in cushing’s disease. Endocrine Pathology. 3(4). 205–208. 4 indexed citations
18.
Verhelst, J., Peter Trainer, Trevor A. Howlett, et al.. (1991). Short and long‐term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clinical Endocrinology. 35(2). 169–178. 233 indexed citations
20.
Verhelst, J., et al.. (1991). Cushing's Disease and Hyperprolactinemia Due to a Mixed ACTH- and Prolactin-Secreting Pituitary Macroadenoma. Pathology - Research and Practice. 187(5). 598–602. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026